Market Cap 606.85M
Revenue (ttm) 75.39M
Net Income (ttm) -287.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -381.39%
Debt to Equity Ratio 0.00
Volume 5,078,949
Avg Vol 1,844,358
Day's Range N/A - N/A
Shares Out 266.16M
Stochastic %K 73%
Beta 2.07
Analysts Strong Sell
Price Target $8.63

Company Profile

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in the United Kingdom and internationally. The company offers AUCATZYL, a gene therapy product consisting of autologous T cells that are transduced with a lentiviral vector to express a novel anti-CD19 chimeric antigen receptor. It also develops obe-cel, which is in phase 1 to treat systemic lupus erythematosus, progressive multiple sclerosis, B-NHL...

Industry: Biotechnology
Sector: Healthcare
Phone: 44 20 3829 6230
Address:
The Mediaworks, 191 Wood Lane White City, London, United Kingdom
Arthur_PL
Arthur_PL Aug. 19 at 6:56 PM
$AUTL — an interesting potential M&A angle: Moderna. This is not just a random theory. Moderna has a licensing agreement with Autolus covering proprietary targeting technology for up to 4 immuno-oncology targets, and in 2022 it exercised an option on one undisclosed target. Autolus still lists Moderna as a partner. At the same time, Moderna is expanding its oncology pipeline, making AUTL a strategically plausible fit. I found no credible evidence that takeover talks are currently underway, so I view this as a strategic M&A thesis, not a rumor. BioNTech remains the more obvious potential buyer given its equity stake and broader strategic relationship with AUTL. Sources: https://www.autolus.com/about-us/our-partners/ https://www.modernatx.com/research/product-pipeline https://www.modernatx.com/media-center/all-media/blogs/building-the-future-of-oncology
0 · Reply
TricksterT
TricksterT Aug. 19 at 6:48 PM
$AUTL I love this stock!
0 · Reply
sbale
sbale Aug. 19 at 6:16 PM
$AUTL My scanner found this. Bought today.
1 · Reply
gandolf63
gandolf63 Aug. 19 at 6:03 PM
$AUTL if we can close above $2.52 its off to the races upward
0 · Reply
Mancunian
Mancunian Aug. 19 at 5:28 PM
$AUTL With the Moderna announcement today I expect Autolus to come under the major pharma microscope…Let’s not forget that Moderna licences technology from Autolus .
1 · Reply
Dirk1969
Dirk1969 Aug. 19 at 5:25 PM
$AUTL Almost two years later, it is beginning to dawn on people that this might well turn out to be a decisive turning point. ✅📈 https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-obecabtagene-autoleucel-adults-relapsed-or-refractory-b-cell-precursor-acute
0 · Reply
gandolf63
gandolf63 Aug. 19 at 5:13 PM
0 · Reply
MedHS55
MedHS55 Aug. 19 at 5:12 PM
$AUTL One has to wonder if the bods/algos are moving the stock the other way?
0 · Reply
PatriotTrader17
PatriotTrader17 Aug. 19 at 5:08 PM
$AUTL weird that’s exactly what happened…..
0 · Reply
XX1XX
XX1XX Aug. 19 at 3:37 PM
$AUTL lets get a count from the LONGS that been here a while. I feel like we own several million shares. I'm at 108K
5 · Reply
Latest News on AUTL
Autolus Therapeutics Slides: Corporate presentation

Aug 18, 2026, 8:00 AM EDT - 1 day ago

Autolus Therapeutics Slides: Corporate presentation


Autolus Therapeutics Earnings Call Transcript: Q2 2026

Aug 11, 2026, 8:30 AM EDT - 8 days ago

Autolus Therapeutics Earnings Call Transcript: Q2 2026


Autolus Therapeutics Earnings release: Q2 2026

Aug 11, 2026, 8:30 AM EDT - 8 days ago

Autolus Therapeutics Earnings release: Q2 2026


Autolus Therapeutics Earnings release: Q2 2026

Aug 11, 2026, 8:30 AM EDT - 8 days ago

Autolus Therapeutics Earnings release: Q2 2026


Autolus Therapeutics Slides: Q2 2026

Aug 11, 2026, 8:30 AM EDT - 8 days ago

Autolus Therapeutics Slides: Q2 2026


Autolus Therapeutics Quarterly report: Q2 2026

Aug 11, 2026, 8:30 AM EDT - 8 days ago

Autolus Therapeutics Quarterly report: Q2 2026


Autolus Therapeutics reports Q2 EPS (15c), consensus (19c)

2026-08-11T11:20:11.000Z - 8 days ago

Autolus Therapeutics reports Q2 EPS (15c), consensus (19c)


Autolus Therapeutics Receives Prix Galien UK Award

Jun 12, 2026, 4:00 AM EDT - 2 months ago

Autolus Therapeutics Receives Prix Galien UK Award


Autolus Therapeutics Slides: Corporate presentation

May 21, 2026, 7:00 AM EDT - 3 months ago

Autolus Therapeutics Slides: Corporate presentation


Autolus Therapeutics reports Q1 EPS (27c), consensus (26c)

2026-05-14T12:45:01.000Z - 3 months ago

Autolus Therapeutics reports Q1 EPS (27c), consensus (26c)


Autolus Therapeutics Earnings Call Transcript: Q1 2026

May 14, 2026, 8:30 AM EDT - 3 months ago

Autolus Therapeutics Earnings Call Transcript: Q1 2026


Autolus Therapeutics Earnings release: Q1 2026

May 14, 2026, 8:30 AM EDT - 3 months ago

Autolus Therapeutics Earnings release: Q1 2026


Autolus Therapeutics Quarterly report: Q1 2026

May 14, 2026, 8:30 AM EDT - 3 months ago

Autolus Therapeutics Quarterly report: Q1 2026


Autolus Therapeutics Slides: Q1 2026

May 14, 2026, 8:30 AM EDT - 3 months ago

Autolus Therapeutics Slides: Q1 2026


Autolus Therapeutics to reduce workforce by approximately 13%

2026-04-29T22:04:39.000Z - 3 months ago

Autolus Therapeutics to reduce workforce by approximately 13%


Autolus Therapeutics Registration statement: Registration filing

Apr 13, 2026, 8:00 AM EDT - 4 months ago

Autolus Therapeutics Registration statement: Registration filing


Autolus Therapeutics Registration statement: Registration filing

Apr 13, 2026, 8:00 AM EDT - 4 months ago

Autolus Therapeutics Registration statement: Registration filing


Autolus Therapeutics Slides: Corporate presentation

Apr 13, 2026, 7:00 AM EDT - 4 months ago

Autolus Therapeutics Slides: Corporate presentation


Autolus Therapeutics files $150M mixed securities shelf

2026-04-13T10:06:09.000Z - 4 months ago

Autolus Therapeutics files $150M mixed securities shelf


Autolus Therapeutics Transcript: Status update

Apr 8, 2026, 1:00 PM EDT - 4 months ago

Autolus Therapeutics Transcript: Status update


Autolus Therapeutics Slides: Status update

Apr 8, 2026, 1:00 PM EDT - 4 months ago

Autolus Therapeutics Slides: Status update


Autolus Therapeutics Earnings Call Transcript: Q4 2025

Mar 27, 2026, 8:30 AM EDT - 5 months ago

Autolus Therapeutics Earnings Call Transcript: Q4 2025


Autolus Therapeutics Annual report: Q4 2025

Mar 27, 2026, 8:30 AM EDT - 5 months ago

Autolus Therapeutics Annual report: Q4 2025


Autolus Therapeutics Earnings release: Q4 2025

Mar 27, 2026, 8:30 AM EDT - 5 months ago

Autolus Therapeutics Earnings release: Q4 2025


Autolus Therapeutics Slides: Q4 2025

Mar 27, 2026, 8:30 AM EDT - 5 months ago

Autolus Therapeutics Slides: Q4 2025


Autolus Therapeutics reports Q4 EPS (34c), consensus (43c)

2026-03-27T11:36:34.000Z - 5 months ago

Autolus Therapeutics reports Q4 EPS (34c), consensus (43c)


Autolus Therapeutics initiated with a Buy at H.C. Wainwright

2026-02-17T11:11:16.000Z - 6 months ago

Autolus Therapeutics initiated with a Buy at H.C. Wainwright


Autolus Therapeutics Earnings Call Transcript: Q3 2025

Nov 12, 2025, 8:30 AM EST - 10 months ago

Autolus Therapeutics Earnings Call Transcript: Q3 2025


Autolus Therapeutics Quarterly report: Q3 2025

Nov 12, 2025, 8:30 AM EST - 10 months ago

Autolus Therapeutics Quarterly report: Q3 2025


Autolus Therapeutics Earnings release: Q3 2025

Nov 12, 2025, 8:30 AM EST - 10 months ago

Autolus Therapeutics Earnings release: Q3 2025


Autolus Therapeutics Slides: Q3 2025

Nov 12, 2025, 8:30 AM EST - 10 months ago

Autolus Therapeutics Slides: Q3 2025


Autolus Therapeutics Earnings Call Transcript: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Earnings Call Transcript: Q2 2025


Autolus Therapeutics Quarterly report: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Quarterly report: Q2 2025


Autolus Therapeutics Earnings release: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Earnings release: Q2 2025


Autolus Therapeutics Slides: Q2 2025

Aug 12, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Slides: Q2 2025


Autolus Therapeutics Earnings Call Transcript: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Earnings Call Transcript: Q1 2025


Autolus Therapeutics Quarterly report: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Quarterly report: Q1 2025


Autolus Therapeutics Earnings release: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Earnings release: Q1 2025


Autolus Therapeutics Slides: Q1 2025

May 8, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Slides: Q1 2025


Autolus Therapeutics Transcript: Status Update

Apr 23, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Transcript: Status Update


Autolus Therapeutics Press release: Status Update

Apr 23, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Press release: Status Update


Autolus Therapeutics Slides: Status Update

Apr 23, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Slides: Status Update


Autolus Therapeutics Earnings Call Transcript: Q4 2024

Mar 20, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Earnings Call Transcript: Q4 2024


Autolus Therapeutics Annual report: Q4 2024

Mar 20, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Annual report: Q4 2024


Autolus Therapeutics Earnings release: Q4 2024

Mar 20, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Earnings release: Q4 2024


Autolus Therapeutics Slides: Q4 2024

Mar 20, 2025, 8:30 AM EDT - 1 year ago

Autolus Therapeutics Slides: Q4 2024


Autolus Therapeutics Earnings Call Transcript: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Autolus Therapeutics Earnings Call Transcript: Q3 2024


Autolus Therapeutics Quarterly report: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Autolus Therapeutics Quarterly report: Q3 2024


Autolus Therapeutics Earnings release: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Autolus Therapeutics Earnings release: Q3 2024


Autolus Therapeutics Slides: Q3 2024

Nov 12, 2024, 8:30 AM EST - 1 year ago

Autolus Therapeutics Slides: Q3 2024


Autolus Therapeutics Transcript: FDA Announcement

Nov 11, 2024, 8:30 AM EST - 1 year ago

Autolus Therapeutics Transcript: FDA Announcement


Autolus Therapeutics Press release: FDA Announcement

Nov 11, 2024, 8:30 AM EST - 1 year ago

Autolus Therapeutics Press release: FDA Announcement


Autolus Therapeutics Slides: FDA Announcement

Nov 11, 2024, 8:30 AM EST - 1 year ago

Autolus Therapeutics Slides: FDA Announcement


Autolus Therapeutics Earnings Call Transcript: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

Autolus Therapeutics Earnings Call Transcript: Q2 2024


Autolus Therapeutics Quarterly report: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

Autolus Therapeutics Quarterly report: Q2 2024


Autolus Therapeutics Earnings release: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

Autolus Therapeutics Earnings release: Q2 2024


Autolus Therapeutics Slides: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

Autolus Therapeutics Slides: Q2 2024


Autolus Therapeutics Transcript: Status Update

Jun 1, 2024, 9:30 AM EDT - 2 years ago

Autolus Therapeutics Transcript: Status Update


Autolus Therapeutics Earnings Call Transcript: Q1 2024

May 17, 2024, 8:30 AM EDT - 2 years ago

Autolus Therapeutics Earnings Call Transcript: Q1 2024


Autolus Therapeutics Quarterly report: Q1 2024

May 17, 2024, 8:30 AM EDT - 2 years ago

Autolus Therapeutics Quarterly report: Q1 2024


Autolus Therapeutics Earnings release: Q1 2024

May 17, 2024, 8:30 AM EDT - 2 years ago

Autolus Therapeutics Earnings release: Q1 2024


Autolus Therapeutics Slides: Q1 2024

May 17, 2024, 8:30 AM EDT - 2 years ago

Autolus Therapeutics Slides: Q1 2024


Arthur_PL
Arthur_PL Aug. 19 at 6:56 PM
$AUTL — an interesting potential M&A angle: Moderna. This is not just a random theory. Moderna has a licensing agreement with Autolus covering proprietary targeting technology for up to 4 immuno-oncology targets, and in 2022 it exercised an option on one undisclosed target. Autolus still lists Moderna as a partner. At the same time, Moderna is expanding its oncology pipeline, making AUTL a strategically plausible fit. I found no credible evidence that takeover talks are currently underway, so I view this as a strategic M&A thesis, not a rumor. BioNTech remains the more obvious potential buyer given its equity stake and broader strategic relationship with AUTL. Sources: https://www.autolus.com/about-us/our-partners/ https://www.modernatx.com/research/product-pipeline https://www.modernatx.com/media-center/all-media/blogs/building-the-future-of-oncology
0 · Reply
TricksterT
TricksterT Aug. 19 at 6:48 PM
$AUTL I love this stock!
0 · Reply
sbale
sbale Aug. 19 at 6:16 PM
$AUTL My scanner found this. Bought today.
1 · Reply
gandolf63
gandolf63 Aug. 19 at 6:03 PM
$AUTL if we can close above $2.52 its off to the races upward
0 · Reply
Mancunian
Mancunian Aug. 19 at 5:28 PM
$AUTL With the Moderna announcement today I expect Autolus to come under the major pharma microscope…Let’s not forget that Moderna licences technology from Autolus .
1 · Reply
Dirk1969
Dirk1969 Aug. 19 at 5:25 PM
$AUTL Almost two years later, it is beginning to dawn on people that this might well turn out to be a decisive turning point. ✅📈 https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-obecabtagene-autoleucel-adults-relapsed-or-refractory-b-cell-precursor-acute
0 · Reply
gandolf63
gandolf63 Aug. 19 at 5:13 PM
0 · Reply
MedHS55
MedHS55 Aug. 19 at 5:12 PM
$AUTL One has to wonder if the bods/algos are moving the stock the other way?
0 · Reply
PatriotTrader17
PatriotTrader17 Aug. 19 at 5:08 PM
$AUTL weird that’s exactly what happened…..
0 · Reply
XX1XX
XX1XX Aug. 19 at 3:37 PM
$AUTL lets get a count from the LONGS that been here a while. I feel like we own several million shares. I'm at 108K
5 · Reply
Biotechs5454
Biotechs5454 Aug. 19 at 3:31 PM
$AUTL Added 70k shares. Realize we may pull back but this is one of the few “value” commercial small cap biotechs left. Itin is sand bagging their updated guidance as well IMHO.
0 · Reply
PatriotTrader17
PatriotTrader17 Aug. 19 at 3:18 PM
$AUTL The price action is very consistent with most days where it runs, retraces, retests previous day highs and then usually holds going into AH.
0 · Reply
Gugger
Gugger Aug. 19 at 3:11 PM
$AUTL Nice Volume 💪, already yestardays full day volume. I told u Funds and institutionals are building up positions, not easy to get several 10 Mio shs in the market. Additionaly we have the shorts getting nervous about closing their position, because AUTL avoided equity dilution. Seems it is overbought for a short time, but after consolidation we should move on to much higher prices.
0 · Reply
gandolf63
gandolf63 Aug. 19 at 3:04 PM
$AUTL the market realizes and knows there’s going to be some excellent readouts on auto immune by the end of the year
0 · Reply
TricksterT
TricksterT Aug. 19 at 2:47 PM
$AUTL that was a fun little pump and dump. Let’s hold $2.40 into close today.
1 · Reply
Gugger
Gugger Aug. 19 at 2:25 PM
$AUTL Hold on, only traders sell 💪💪
0 · Reply
Gabiibra5
Gabiibra5 Aug. 19 at 2:24 PM
0 · Reply
gandolf63
gandolf63 Aug. 19 at 2:23 PM
0 · Reply
XX1XX
XX1XX Aug. 19 at 2:23 PM
$AUTL there will be some technical trading as the algos will see this as over bought in the short term so we might get some pull backs here and there but make no mistake about it, the short trade is officially over after AUTL pre announced earning and basically trapped 14M short shares. combined with the extra cash and no dilution the only word anyone should be focusing on now is PATIENTS this is how you get rich. There is only one direction that AUTL will go from here unless there is some unforeseen news like the facility burning down. HOLD and dont sell for pennies. I look forward to the days when a $.50 move up or down is just a normal day.
0 · Reply
Gabiibra5
Gabiibra5 Aug. 19 at 2:23 PM
$AUTL Weekly — breakout , and the fundamentals just backed it up Chart: Big reversal week, +12.33%, closing at $2.51 on rising volume and aproaching first fib level — one of the heavier weekly volume prints of the past year. Stock topped near $7.45 in early 2024, bled down to a $1.11 low, then chopped in a $1.50–$2.50 range for over a year with higher lows forming. This week's candle broke through the 0.786 Fib retrace ($1.94, measured off the $5.00–$1.11 leg) and is now testing 0.618 resistance around $2.59. Above that: $3.05 (0.5) and $3.51 (0.382), which capped multiple rallies in 2024–2025. Support to hold now: $1.94. Several past earnings events (marked "E") failed to produce a durable breakout, so follow-through on volume next week matters. Fundamentals — Q2 2026 (reported Aug 11): AUCATZYL (obe-cel) net product revenue hit $45.7M, up 119% YoY and ~70% sequentially. Gross margin jumped to 55% in Q2 from just 6% in Q1 — a real inflection, not just top-line growth.... continue below
1 · Reply
rusi1
rusi1 Aug. 19 at 2:21 PM
$AUTL only 1 dollar to my avg.
0 · Reply
The_Camel
The_Camel Aug. 19 at 2:20 PM
$AUTL you’re spot on again! 😂 @Michael_garic
0 · Reply